• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Olympus buys Veran Technologies for $340M

Olympus buys Veran Technologies for $340M

December 4, 2020 By Sean Whooley

Olympus (TYO:7733) announced today that it entered into an agreement to acquire Veran Medical Technologies for up to $340 million.

St. Louis, Mo.-based Veran Medical develops advanced medical devices specializing in interventional pulmonology, including navigation products to develop solutions for improved diagnosis of peripheral lung cancer, according to a news release.

The acquisition by Olympus is slated to be implemented through its Olympus Corporation of the Americas (OCA) subsidiary as the company seeks to strengthen its position in the medical device industry through a plan to scale its therapeutic solutions division.

“We are very excited about acquiring VMT because its portfolio of devices will complement our product portfolio and further strengthen our position in respiratory medical devices,” Nacho Abia, global chief operating officer and CEO of OCA, said in the release. “The most significant part of this deal is that we will secure immediate access to VMT’s unique electromagnetic navigation system with proprietary devices to build a stronger future respiratory product portfolio.”

Olympus believes its endoscope technologies will combine with VMT’s navigation products to develop solutions for improving the diagnosis of peripheral lung cancer, with the company expecting the acquisition to provide immediate incremental revenue within the U.S. market.

Already a leader in bronchoscopy systems, Olympus’ endoscope technologies will combine perfectly with VMT’s navigation products to develop solutions for improved diagnosis of peripheral lung cancer.

“We are proud to be joining forces with Olympus, a company with a 100-year legacy and a global reputation for quality, leadership and innovation,” VMT CEO Jason Pesterfield said. “Olympus has a clear strategy to become a global medtech leader, and we’re excited to contribute our unique capabilities and become part of this journey.”

Filed Under: Business/Financial News, Diagnostics, Featured, Imaging, Mergers & Acquisitions, Oncology, Respiratory Tagged With: Olympus, Veran Medical Technologies

More recent news

  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
  • GE HealthCare launches new MRI scanner
  • HistoSonics earns first major reimbursement win for non-invasive histotripsy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy